U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. About FDA
  3. FDA Organization
  4. Office of Inspections and Investigations
  5. OII Inspectorates
  6. Office of Bioresearch Monitoring Inspectorate (OBMI)
  7. FDA Clinical Trial Requirements, Regulations, Compliance, and GCP Conference - 06/13/2023
  1. Office of Bioresearch Monitoring Inspectorate (OBMI)

Conference | Virtual

Event Title
FDA Clinical Trial Requirements, Regulations, Compliance, and GCP Conference
June 13 - 15, 2023

FDA/ORA Bioresearch Monitoring-West (BIMO-W) and SOCRA are pleased to offer this jointly sponsored conference. This conference on FDA’s clinical trial requirements is designed to aid the Clinical Research Professional’s understanding of the mission, responsibilities and authority of the FDA and to facilitate interaction with FDA representatives.

This three-day live, virtual conference is intended to share information among FDA representatives and the regulated community, to facilitate the understanding of regulations, guidelines and practices, and to suggest methods and opportunities to enhance the research professional’s product development experience. The program will focus on the relationships among the FDA and clinical trial staff, investigators and IRBs. The workshop will highlight three areas that present challenges to sponsors and investigational sites: FDA Clinical Research Requirements, Enhancing Success through Communication and Financial Incentives, and Assuring Confidence in Clinical Research.
 

Back to Top